174 related articles for article (PubMed ID: 11162306)
1. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Noll M; Bateman RL; D'Andrea AD; Grompe M
Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
[TBL] [Abstract][Full Text] [Related]
2. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
Cohen-Haguenauer O; Péault B; Bauche C; Daniel MT; Casal I; Levy V; Dausset J; Boiron M; Auclair C; Gluckman E; Marty M
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2340-5. PubMed ID: 16461901
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1.
Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA
Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999
[TBL] [Abstract][Full Text] [Related]
4. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
5. Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models.
Liu JM; Kim S; Walsh CE
Blood Cells Mol Dis; 1995; 21(1):56-63. PubMed ID: 7544677
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
Williams DA; Croop J; Kelly P
Curr Opin Mol Ther; 2005 Oct; 7(5):461-6. PubMed ID: 16248281
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for fanconi anemia.
Croop JM
Curr Hematol Rep; 2003 Jul; 2(4):335-40. PubMed ID: 12901331
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
[TBL] [Abstract][Full Text] [Related]
10. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer for the eventual treatment of Fanconi's anemia.
Liu JM
Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
[TBL] [Abstract][Full Text] [Related]
12. Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion.
Habi O; Delisle MC; Messier N; Carreau M
Stem Cells; 2005 Sep; 23(8):1135-41. PubMed ID: 16020692
[TBL] [Abstract][Full Text] [Related]
13. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy.
Machl AW; Planitzer S; Kubbies M
Gene Ther; 1997 Apr; 4(4):339-45. PubMed ID: 9176520
[TBL] [Abstract][Full Text] [Related]
14. Expression of hHR21sp gene by peripheral blood and hematopoietic cells of normal subjects and Fanconi anemia patients.
Deng Y; Li S; Li X; Magali T
Chin Med J (Engl); 2001 Dec; 114(12):1295-9. PubMed ID: 11793857
[TBL] [Abstract][Full Text] [Related]
15. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia.
Battaile KP; Bateman RL; Mortimer D; Mulcahy J; Rathbun RK; Bagby G; Fleming WH; Grompe M
Blood; 1999 Sep; 94(6):2151-8. PubMed ID: 10477746
[TBL] [Abstract][Full Text] [Related]
16. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
17. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
18. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
19. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
20. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
